Cite
HARVARD Citation
Bradford, D. et al. (2020). FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma. Oncologist. pp. e1077-e1082. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bradford, D. et al. (2020). FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma. Oncologist. pp. e1077-e1082. [Online].